• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER, INC. (IRWINDALE) GENERIC - LASSO

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER, INC. (IRWINDALE) GENERIC - LASSO Back to Search Results
Model Number D-1220-00
Device Problem Insufficient Information (3190)
Patient Problems Fever (1858); Hematoma (1884); Hemoptysis (1887); Complaint, Ill-Defined (2331)
Event Date 05/30/2015
Event Type  Injury  
Manufacturer Narrative
No device was received for analysis at the time of submission of the initial 3500a.Since the product was not returned for analysis, no product failure analysis can be conducted and no determination of possible contributing factors could be made.Device history record (dhr) review cannot be conducted because the no lot number was provided by the customer.(b)(4).The device is not returned to bwi.
 
Event Description
This complaint is from a literature source.It was reported that 240 patients with af underwent catheter ablation from july 2013 and june 2015.Among them, 1 patient in group d developed hemoptysis, and the patient developed a large groin hematoma two days following the procedure and a high fever of 38.6°c.Dabigatran was discontinued imminently.Two days later, massive hemoptysis occurred and pulmonary computed tomography (ct) presented bilateral pulmonary frosted glass.At three days later, no hemoptysis occurred and a lung ct presented markedly reduced frosted glass.Based on the facts of the case and the author¿s assessment, there were no reported malfunction with any of the bwi catheters and systems used during the case.Thus, this event is unrelated to the device and most likely related to the procedure.Title: ¿use of dabigatran vs.Warfarin with low-molecular-weight heparin bridging in catheter ablation for atrial fibrillation patients with a low chads2 score¿.The purpose of this study was to compare the efficacy and safety of dabigatran and interrupted warfarin with low-molecular-weight heparin bridging in non-valvular atrial fibrillation (af) catheter ablation.Suspect device is a lasso catheter, however catalog and lot number is unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GENERIC - LASSO
Type of Device
GENERIC - LASSO
Manufacturer (Section D)
BIOSENSE WEBSTER, INC. (IRWINDALE)
15715 arrow highway
irwindale CA 91706
Manufacturer (Section G)
BIOSENSE WEBSTER, INC. (IRWINDALE)
15715 arrow highway
irwindale CA 91706
Manufacturer Contact
joaquin kurz
33 technology drive
irvine, CA 92618
9497893837
MDR Report Key6674685
MDR Text Key78656789
Report Number2029046-2017-00214
Device Sequence Number1
Product Code DRF
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
NI
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,literature
Reporter Occupation Other
Type of Report Initial
Report Date 06/14/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberD-1220-00
Device Catalogue NumberD122000
Device Lot NumberUNKNOWN_LASSO
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 06/13/2017
Initial Date FDA Received06/28/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age55 YR
-
-